Posatex
Active substance
ATC code
Species
Dogs.
Indications
Treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular Malassezia pachydermatis.
Dose to be administered and administration route
Auricular use.
One drop contains 267 mcg orbifloxacin, 27 mcg mometasone furoate and 27 mcg posaconazole.
The external ear canal should be meticulously cleaned and dried before treatment. Excess hair around the treatment area should be cut.
Shake well before use.
Dogs weighing less than 2 kg, apply 2 drops to the ear once a day. Dogs weighing 2 - 15 kg, apply 4 drops to the ear once a day.
Dogs weighing 15 kg or more, apply 8 drops to the ear once a day.
Treatment should continue for 7 consecutive days.
After application, the base of the ear may be massaged briefly and gently to allow the veterinary medicinal product to penetrate the lower part of the ear canal.
Posatex is a viscous suspension. The inherent viscosity will result in a reduced delivery volume compared to the fill volume (see section 5.4).
Adverse reactions
Dogs:
|
Common (1 to 10 animals / 100 animals treated): |
Pinnal erythema1 |
|
Uncommon (1 to 10 animals / 1,000 animals treated): |
Impaired hearing2 |
1 Mild
2 Usually temporary and primarily in geriatric dogs.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
